QIAGEN N.V.
QGENNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for QGEN. That does not mean none is planned.
Get an email about QGEN's next catalysts
Track QIAGEN (QGEN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
How QGEN's past catalysts played out
Market Overview
Stock performance and key metrics
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer (CEO).
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NEU-411 | Phase 2 | Parkinson Disease | - | - |
Frequently asked questions
What is in QIAGEN N.V.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in QIAGEN N.V.'s (QGEN) pipeline across Phase 2. Its lead program is NEU-411 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is QIAGEN N.V.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for QIAGEN N.V. (QGEN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track QGEN biotech catalysts?→
Add QGEN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow QIAGEN N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.